- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Compulsion.
Displaying page 1 of 1.
EudraCT Number: 2008-004102-14 | Sponsor Protocol Number: 8123 | Start Date*: 2008-10-23 | |||||||||||
Sponsor Name:Kansanterveyslaitos | |||||||||||||
Full Title: Rahapeliriippuvuuden hoitaminen kohdennetulla naltreksonilääkityksellä ja oppimismallilla | |||||||||||||
Medical condition: Peliriippuvuus, muuten terveitä | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021123-26 | Sponsor Protocol Number: 03062010 | Start Date*: 2010-10-29 | |||||||||||
Sponsor Name:National Institute for Health and Welfare | |||||||||||||
Full Title: Kaksoissokkoutettu kliininen hoitotutkimus: Rahapeliriippuvuuden hoitaminen opiaattisalpaaja naltreksonilla ja oppimismallilla | |||||||||||||
Medical condition: Pathological gambling dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001828-56 | Sponsor Protocol Number: NalPilo | Start Date*: 2016-12-09 | |||||||||||
Sponsor Name:National Institute for Health and Welfare | |||||||||||||
Full Title: | |||||||||||||
Medical condition: Problem gambling | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011115-20 | Sponsor Protocol Number: NordLOTS protocol step 3 1.1 | Start Date*: 2009-08-14 | ||||||||||||||||
Sponsor Name:The Centre for Child and Adolescent Mental Health, Eastern and Southern Norway (R.BUP) | ||||||||||||||||||
Full Title: Nordic Longterm OCD treatment Study: A Nordic Multicenter treatment study evaluating a stepped care model based on the "Expert Clinical Guidelines". The study is performed with no sponsor from phar... | ||||||||||||||||||
Medical condition: Obsessive Compulsive Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) NO (Ongoing) DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004613-34 | Sponsor Protocol Number: NordLOTS protocol 1.4 | Start Date*: 2008-03-14 | ||||||||||||||||
Sponsor Name:The Centre for Child and Adolescent Mental Health, Eastern and Southern Norway (R.BUP) | ||||||||||||||||||
Full Title: Nordic Longterm OCD treatment Study: A Nordic Multicenter treatment study evaluating a stepped care model based on the "Expert Clinical Guidelines". The study is performed with no sponsor from phar... | ||||||||||||||||||
Medical condition: Obsessive Compulsive Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001946-93 | Sponsor Protocol Number: NalGamb | Start Date*: 2017-10-31 | |||||||||||
Sponsor Name:National Instute of Health and Welfare | |||||||||||||
Full Title: Double-blind, placebo-controlled randomised study on the efficacy of naloxone nasal spray for the treatment of gambling disorder | |||||||||||||
Medical condition: Problem gambling | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005111-40 | Sponsor Protocol Number: CN138-178 | Start Date*: 2017-04-07 |
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc | ||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Flexible- Dosed Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents with Autistic Disorder | ||
Medical condition: Autistic Disorder | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2020-000867-21 | Sponsor Protocol Number: NGAM-13 | Start Date*: 2021-08-16 |
Sponsor Name:Octapharma Pharmazeutika Produktionsges.m.b.H. | ||
Full Title: A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome | ||
Medical condition: Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a research diagnosis given to patients who have an abrupt, dramatic onset of neuropsychiatric symptoms including obsessions/compulsio... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA SE (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.